Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Clean Energy and Precious...
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Clean Energy & Precious Metals...
NEW YORK, June 5 /PRNewswire/ -- The Stilwell Group announced today that it is continuing to solicit proxies to vote for its three nominees for director at the June 22, 2006 annual stockholders...
RNS Number:1480U Skyepharma PLC 13 January 2004 For Immediate Release: 13 January, 2004 SkyePharma and Critical Therapeutics to develop controlled release formulation for treatment...
RNS Number:0914U Skyepharma PLC 12 January 2004 For Immediate Release 12 January, 2004 SkyePharma PLC Press Announcement SkyePharma Welcomes Canadian Approval of Paxil...
RNS Number:0064U Skyepharma PLC 08 January 2004 Immediate Release 8 January 2004 SkyePharma PLC ("the Company") Notification of Major Interest in Shares In accordance with...
RNS Number:0065U Skyepharma PLC 08 January 2004 Immediate Release 8 January 2004 SkyePharma PLC ("the Company") Notification of Major Interest in Shares In accordance with...
RNS Number:8371T Skyepharma PLC 05 January 2004 For Immediate Release 5 January, 2004 GLAXOSMITHKLINE LICENSES SKYEPHARMA FORMULATION TECHNOLOGY FOR RESPIRATORY DRUGS LONDON...
RNS Number:8370T Skyepharma PLC 05 January 2004 For Immediate Release 5 January, 2004 SKYEPHARMA PROVIDES END-2003 TRADING UPDATE LONDON, UK, 5 January 2004-- SkyePharma PLC...
RNS Number:7583T Skyepharma PLC 31 December 2003 For Immediate Release 31 December 2003 SkyePharma PLC ("the Company") As a result of transactions on 31 December 2003 by the SkyePharma...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
